World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Hemoperfusion in Poisoning, Kidney Failure, Liver Failure, and Immunology

      https://doi.org/10.1142/9789812770370_0010Cited by:0 (Source: Crossref)
      Abstract:

      The following sections are included:

      • Introduction

        • Artificial kidney machine

        • Hemoperfusion based on artificial cells

      • Development and Clinical Trials

        • Treatment of patients with severe accidental or suicidal poisoning

        • Hemoperfusion for removal of unwanted or toxic substances from blood under other conditions

        • Treatment of patients with terminal kidney failure

        • Treatment of patients with hepatic coma

        • Protein-coated artificial cells in immunoadsorption

      • Basic Principle of Artificial Cell in Hemoperfusion

        • Permeability and transport characteristics

        • Experimental analysis

      • Artificial Cells Containing Activated Charcoal in Hemoperfusion

        • Why use activated charcoal for artificial cell hemoperfusion?

        • Effects on embolism

        • Effects of hemoperfusion on platelets

        • Clearance of the ACAC artificial cell artificial kidney

        • Improvements in hydrodynamics

      • Hemoperfusion in Acute Suicidal or Accidental Poisoning

        • Preclinical studies

        • First clinical trials in acute poisoning

        • Result of clinical trials on 11 adult patients with suicidal or accidental drug poisoning

        • Pediatric patient with accidental theophylline overdose

        • Routine clinical uses in patients around the world

      • Hemoperfusion in Terminal Renal Failure Patients

      • Hemoperfusion Alone Supplemented by Hemodialysis

        • General clinical results

        • First patient on long-term hemoperfusion

        • Hemoperfusion and removal of uremic metabolites

      • Conjoint Hemoperfusion-Hemodialysis

      • Miniaturized Artificial Kidney Based on Hemoperfusion-Ultrafiltration

      • Hemoperfusion in Liver Failure

        • First observation of recovery of consciousness in hepatic coma

        • Results around the world on effect of hemoperfusion on hepatic coma

        • Control studies in galactosamine-induced hepatic failure rats

      • Immunoadsorption

        • Protein coated artificial cells in immunoadsorption

      • Detailed Procedures for the Laboratory Preparation of ACAC Hemoperfusion Device

        • The extracorporeal shunt chamber

        • Preparation of activated charcoal

        • Preparation of artificial cells containing activated charcoal

        • Procedure for hemoperfusion